Cilofexor Recruiting Phase 1 Trials for compensated liver disease / Primary Sclerosing Cholangitis (PSC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04060147Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis